Stephanie Coulter is a Cardiology physician affiliated with Houston Methodist. OpenAlex indexes 62 publications with 1,707 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6624 Fannin St
Suite 2600
Houston, TX 770302338
Telephone
713-790-9401Provider last certified this registry record 1 Mar 2023.
Industry payments
46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202514 payments
- Novartis Pharmaceuticals CorporationProgram year202511 payments
- Actelion Pharmaceuticals US, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79%Statin22%Atorvastatin Calcium67%Rosuvastatin Calcium19%Pravastatin Sodium7%Simvastatin5%Pitavastatin Calcium2%Livalo2%Part D≥303 patientsBeta blocker13.7%Metoprolol Succinate59%Carvedilol13%Nebivolol Hcl13%Atenolol7%Metoprolol Tartrate6%Bisoprolol Fumarate2%Part D<11 patients+ 17 more classes in this area
Blood & clotting
7.6%Factor Xa inhibitor4.7%Eliquis92%Xarelto8%Part D<11 patientsP2Y12 inhibitor2.3%Clopidogrel90%Brilinta10%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
7.5%SGLT2 inhibitor3.4%Jardiance88%Farxiga12%Part D≥58 patientsBiguanide (metformin)1.5%Metformin Hcl85%Metformin Hcl Er16%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Validation and longitudinal trajectory analysis of an AI-based ECG model for aortic stenosis: from community screening to pre-TAVR risk stratification
European Heart Journal - Digital Health
2026 - Prevalence of Cardiometabolic Risk Factors in Women: Insights From the Houston HeartReach Study
Texas Heart Institute Journal
2024 - Spontaneous Right Intrapetrous Internal Carotid Dissection in a Patient With Active COVID-19
Texas Heart Institute Journal
2024 - Mitral regurgitation carries greater prognostic significance than mitral stenosis in patients undergoing transcatheter aortic valve replacement
Journal of Cardiovascular Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Bita Esmaeli, MD
Houston Methodist
Sherif Nagueh, MD
Houston Methodist
Neal Kleiman, MD
Houston Methodist
Miguel Quinones, MD
Houston Methodist
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”